SRCM
BKYI

Signature Resources Capital Management’s BIO-key International BKYI Stock Holding History

Signature Resources Capital Management’s Portfolio BKYI Stock Details BKYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$539 – 681
2025
Q4 		$539 Buy
+100
New +$764 ﹤0.01% 604

Other funds holding BKYI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Signature Resources Capital Management's BKYI Position: Q1 2026 in Review

Signature Resources Capital Management sold out of BIO-key International (BKYI) in Q1 2026, closing a stake of 100 shares — an estimated $539 sold.

Signature Resources Capital Management first reported a position in BKYI in Q4 2025 and held it in 1 quarter. The position peaked at $539 in Q4 2025. 10 funds tracked by Wall St. Rank hold BKYI as of Q1 2026.

  • Signature Resources Capital Management reported no remaining BIO-key International position as of Q1 2026 after selling out during the quarter.
  • Signature Resources Capital Management sold 100 BIO-key International shares in Q1 2026, an estimated $539.
  • Signature Resources Capital Management first reported a position in BIO-key International in Q4 2025 and held it in 1 quarter.
  • Signature Resources Capital Management's BIO-key International position peaked at $539 in Q4 2025.
  • 10 funds tracked by Wall St. Rank held BIO-key International as of Q1 2026.

Based on Signature Resources Capital Management's 13F filing for Q1 2026, filed 1 May 2026.